Skip to main content
Clinical Trials/NCT07192029
NCT07192029RecruitingNot Applicable

Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery: a Randomized Controlled Trial

Xuanwu Hospital, Beijing3 sites in 1 country364 target enrollmentStarted: October 12, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
364
Locations
3
Primary Endpoint
Rate of first-pass reperfusion defined as eTICI 2c-3 reperfusion

Study Overview

Brief Summary

To investigate whether using balloon guide catheter with flow arrest during mechanical thrombectomy, compared to non-flow arrest, improves the rate of first pass expanded Thrombolysis in Cerebral Infarction score (eTICI 2c-3) reperfusion for acute ischemic stroke due to internal carotid artery occlusion

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age ≥18 years;
  • •Clinical diagnosis of acute ischemic stroke with internal carotid artery occlusion confirmed by imaging (CTA/MRA/DSA), including isolated intracranial internal carotid artery (I-type), internal carotid artery intracranial segment involving middle cerebral artery (L-type), or internal carotid artery intracranial segment involving middle and anterior cerebral arteries (T-type) (including tandem embolic occlusions of the internal carotid artery C1 or common carotid artery);
  • •Baseline NIHSS≥6, and meeting local guidelines for mechanical thrombectomy;
  • •Time from onset or last known normal to randomization within 24 hours and proceeding to mechanical thrombectomy;
  • •Signed informed consent (or by legal representative).

Exclusion Criteria

  • •Pre-stroke mRS score >2
  • •Intracranial hemorrhage shown on imaging;
  • •Known or suspected internal carotid artery occlusion caused by dissection or atherosclerosis;
  • •Vascular tortuosity preventing the use of balloon guide catheter;
  • •Prior stent implantation in the target vessel that would impede the use or removal of mechanical thrombectomy devices;
  • •Any other circumstances impeding mechanical thrombectomy implementation;
  • •Acute occlusion of multiple vascular territories in bilateral anterior circulation or in both the anterior and posterior circulations confirmed by CTA/MRA;
  • •Pregnant subjects;
  • •Subjects allergic to contrast agents;
  • •Subjects refusing to cooperate or unable to tolerate interventional procedures;
  • •Subjects whose expected lifetime are less than 90 days;
  • •Midline shift or herniation with ventricular mass effect;
  • •Subjects deemed unable to participate in follow-up by investigators;
  • •Other situations deemed unsuitable for balloon guide catheter use by investigators.

Arms & Interventions

The experimental group

Experimental

Intervention: Balloon guide catheter combined with conventional thrombectomy treatment (Procedure)

The control group

Sham Comparator

Intervention: Standard guide catheter or neurovascular sheath combined with conventional thrombectomy treatment (Procedure)

Outcomes

Primary Outcomes

Rate of first-pass reperfusion defined as eTICI 2c-3 reperfusion

Time Frame: Perioperative

Secondary Outcomes

  • Reperfusion results (eTICI ≥2b, eTICI 3)(Perioperative)
  • Proportion of participants with a Barthel Index score of ≥95(90 ± 7 days after surgery)
  • Ordinal Distribution of mRS Scores (mRS Shift analysis)(90 days (±7 days))
  • Change in stroke severity (NIHSS score)(7 days or discharge (whichever occurs first);)
  • Technical success rate(Perioperative)
  • Number of mechanical thrombectomy attempts(Perioperative)
  • Final angiographic reperfusion results (eTICI ≥2b, eTICI ≥2c, eTICI 3)(Perioperative)
  • Good outcome proportion, defined as mRS score 0-2(90 days (±7 days) post-procedure)
  • Time from groin puncture to successful reperfusion (eTICI ≥2b, eTICI ≥2c);(Perioperative)
  • EQ-5D-5L score(90 ± 7 days after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials